Literature DB >> 489575

Determination of the turn-off reaction for the hormone-activated adenylate cyclase.

D Cassel, F Eckstein, M Lowe, Z Selinger.   

Abstract

Previous work suggested that hormonal activation of adenylate cyclase involves the introduction of GTP to the regulatory site, and subsequent hydrolysis of the bound GTP terminates the activation. In many tissues the turn-off GTPase reaction cannot be readily measured because of a high background of nonspecific GTP hydrolysis. To circumvent this problem a general assay for the turn-off reaction has now been developed. The adenylate cyclase is first activated by hormone and GTP and the introduction of GTP is then stopped either by addition of an excess of guanosine 5'-O-(2-thiodiphosphate) (GDP beta S) or by addition of a receptor blocking agent. The decay of adenylate cyclase activity brought on by these inhibitors is used to calculate the rate constant of the turn-off reaction. In turkey erythrocyte and rat parotid membranes the rate constant of the decay process as determined with GDP beta S is similar to that determined with the beta-adrenergic blocker propranolol. The rate constants (min-1 at 30 degrees C) for various adenylate cyclase preparations are 10 for turkey erythrocyte, 7.5 for rat parotid, and 6.2 for the rat liver enzyme. The finding of similar rate constants in the various preparations indicates that GTP hydrolysis at the regulatory site is a general mechanism for terminating the activation of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 489575

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Endothelin activates voltage-dependent Ca2+ current by a G protein-dependent mechanism in rabbit cardiac myocytes.

Authors:  M R Lauer; M D Gunn; W T Clusin
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

Review 2.  G protein coupling of receptors to ionic channels and other effector systems.

Authors:  L Birnbaumer; A Yatani; A M VanDongen; R Graf; J Codina; K Okabe; R Mattera; A M Brown
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 3.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

4.  On the mechanism of histamine induced enhancement of the cardiac Ca2+ current.

Authors:  J Hescheler; M Tang; B Jastorff; W Trautwein
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

5.  Properties of beta-adrenoceptor sites in metabolizing and nonmetabolizing rat reticulocytes and in resealed reticulocyte ghosts.

Authors:  H Porzig; M Baer; C Chanton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

Review 6.  Activation and attenuation of adenylate cyclase. The role of GTP-binding proteins as macromolecular messengers in receptor--cyclase coupling.

Authors:  L E Limbird
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

7.  Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation.

Authors:  J Moss; M Vaughan
Journal:  Mol Cell Biochem       Date:  1981-07-07       Impact factor: 3.396

8.  Inhibition of dopamine-activated adenylate cyclase and dopamine binding by opiate receptors in rat striatum.

Authors:  S Gentleman; M Parenti; N H Neff; C B Pert
Journal:  Cell Mol Neurobiol       Date:  1983-03       Impact factor: 5.046

9.  Acceleration of the adipocyte adenylate cyclase turn-off reaction by inhibitory hormonal factors.

Authors:  K H Jakobs; K Aktories; G Shultz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels.

Authors:  G G Holz; S G Rane; K Dunlap
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.